| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |